{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T11:26:18Z","timestamp":1774092378910,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T00:00:00Z","timestamp":1295481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2334-11-20","type":"journal-article","created":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T19:15:45Z","timestamp":1295550945000},"source":"Crossref","is-referenced-by-count":37,"title":["Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study"],"prefix":"10.1186","volume":"11","author":[{"name":"the Y\u00e9r\u00e9lon Cohort Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea J","family":"Low","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issouf","family":"Konate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Nagot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdoulaye","family":"Ouedraogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Huet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Noelle","family":"Didelot-Rousseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Segondy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Van de Perre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Mayaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,20]]},"reference":[{"issue":"Suppl 3","key":"1363_CR1","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/j.vaccine.2006.05.031","volume":"24","author":"AN Burchell","year":"2006","unstructured":"Burchell AN, Winer RL, de Sanjose S, Franco EL: Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine. 2006, 24 (Suppl 3): S52-61. 10.1016\/j.vaccine.2006.05.031.","journal-title":"Vaccine"},{"key":"1363_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJM199802123380703","volume":"338","author":"GY Ho","year":"1998","unstructured":"Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998, 338: 423-428. 10.1056\/NEJM199802123380703.","journal-title":"N Engl J Med"},{"key":"1363_CR3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.ajog.2003.12.037","volume":"190","author":"LS Massad","year":"2004","unstructured":"Massad LS, Silverberg MJ, Springer G, Minkoff H, Hessol N, Palefsky JM, Strickler HD, Levine AM, Sacks HS, Moxley M, Heather Watts D: Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus. Am J Obstet Gynecol. 2004, 190: 1241-1248. 10.1016\/j.ajog.2003.12.037.","journal-title":"Am J Obstet Gynecol"},{"key":"1363_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1086\/421467","volume":"190","author":"AB Moscicki","year":"2004","unstructured":"Moscicki AB, Ellenberg JH, Farhat S, Xu J: Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis. 2004, 190: 37-45. 10.1086\/421467.","journal-title":"J Infect Dis"},{"key":"1363_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1128\/CMR.2.2.166","volume":"2","author":"A Roman","year":"1989","unstructured":"Roman A, Fife KH: Human papillomaviruses: are we ready to type?. Clin Microbiol Rev. 1989, 2: 166-190.","journal-title":"Clin Microbiol Rev"},{"key":"1363_CR6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1086\/590560","volume":"47","author":"F Aubin","year":"2008","unstructured":"Aubin F, Pretet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F, Pradat P, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D: Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV). Clin Infect Dis. 2008, 47: 610-615. 10.1086\/590560.","journal-title":"Clin Infect Dis"},{"key":"1363_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1086\/597071","volume":"199","author":"SM Garland","year":"2009","unstructured":"Garland SM, Steben M, Sings HL, James M, Lu S, Railkar R, Barr E, Haupt RM, Joura EA: Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis. 2009, 199: 805-814. 10.1086\/597071.","journal-title":"J Infect Dis"},{"key":"1363_CR8","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/sj.bjc.6602736","volume":"93","author":"SR Wall","year":"2005","unstructured":"Wall SR, Scherf CF, Morison L, Hart KW, West B, Ekpo G, Fiander AN, Man S, Gelder CM, Walraven G, Borysiewicz LK: Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. Br J Cancer. 2005, 93: 1068-1076. 10.1038\/sj.bjc.6602736.","journal-title":"Br J Cancer"},{"key":"1363_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/sti.77.4.248","volume":"77","author":"P Mayaud","year":"2001","unstructured":"Mayaud P, Gill DK, Weiss HA, Uledi E, Kopwe L, Todd J, ka-Gina G, Grosskurth H, Hayes RJ, Mabey DC, Lacey CJ: The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania. Sex Transm Infect. 2001, 77: 248-254. 10.1136\/sti.77.4.248.","journal-title":"Sex Transm Infect"},{"key":"1363_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/sj.bjc.6603252","volume":"95","author":"MN Didelot-Rousseau","year":"2006","unstructured":"Didelot-Rousseau MN, Nagot N, Costes-Martineau V, Valles X, Ouedraogo A, Konate I, Weiss HA, Van de Perre P, Mayaud P, Segondy M: Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer. 2006, 95: 355-362. 10.1038\/sj.bjc.6603252.","journal-title":"Br J Cancer"},{"key":"1363_CR11","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/jnci\/djp205","volume":"101","author":"AK Chaturvedi","year":"2009","unstructured":"Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA: Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst. 2009, 101: 1120-1130. 10.1093\/jnci\/djp205.","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 1","key":"1363_CR12","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1016\/j.jcv.2004.10.020","volume":"32","author":"CJ Lacey","year":"2005","unstructured":"Lacey CJ: Therapy for genital human papillomavirus-related disease. J Clin Virol. 2005, 32 (Suppl 1): S82-90. 10.1016\/j.jcv.2004.10.020.","journal-title":"J Clin Virol"},{"key":"1363_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/00007435-200208000-00001","volume":"29","author":"MJ Silverberg","year":"2002","unstructured":"Silverberg MJ, Ahdieh L, Munoz A, Anastos K, Burk RD, Cu-Uvin S, Duerr A, Greenblatt RM, Klein RS, Massad S, et al: The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis. 2002, 29: 427-435. 10.1097\/00007435-200208000-00001.","journal-title":"Sex Transm Dis"},{"key":"1363_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0029-7844(00)00948-0","volume":"96","author":"I Heard","year":"2000","unstructured":"Heard I, Tassie JM, Schmitz V, Mandelbrot L, Kazatchkine MD, Orth G: Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1). Obstet Gynecol. 2000, 96: 403-409. 10.1016\/S0029-7844(00)00948-0.","journal-title":"Obstet Gynecol"},{"key":"1363_CR15","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1097\/QAD.0b013e3283021aa3","volume":"22","author":"JC Dolev","year":"2008","unstructured":"Dolev JC, Maurer T, Springer G, Glesby MJ, Minkoff H, Connell C, Young M, Schowalter K, Cox C, Hessol NA: Incidence and risk factors for verrucae in women. AIDS. 2008, 22: 1213-1219. 10.1097\/QAD.0b013e3283021aa3.","journal-title":"AIDS"},{"key":"1363_CR16","volume-title":"Scaling up antiretroviral therapy in resource-limited settings : guidelines for a public health approach","author":"World Health Organization. Dept. of HIV\/AIDS. Interim WHO Antiretroviral Treatment Working Group","year":"2002","unstructured":"World Health Organization. Dept. of HIV\/AIDS. Interim WHO Antiretroviral Treatment Working Group: Scaling up antiretroviral therapy in resource-limited settings : guidelines for a public health approach. 2002, Geneva: World Health Organization"},{"key":"1363_CR17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/JCM.29.2.297-301.1991","volume":"29","author":"RP Nugent","year":"1991","unstructured":"Nugent RP, Krohn MA, Hillier SL: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991, 29: 297-301.","journal-title":"J Clin Microbiol"},{"key":"1363_CR18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/01.qai.0000152399.54648.b9","volume":"39","author":"N Nagot","year":"2005","unstructured":"Nagot N, Ouedraogo A, Ouangre A, Cartoux M, Defer MC, Meda N, Van de Perre P: Is sexually transmitted infection management among sex workers still able to mitigate the spread of HIV infection in West Africa?. J Acquir Immune Defic Syndr. 2005, 39: 454-458. 10.1097\/01.qai.0000152399.54648.b9.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1363_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/QAI.0b013e3180640cf5","volume":"45","author":"F Rouet","year":"2007","unstructured":"Rouet F, Chaix ML, Nerrienet E, Ngo-Giang-Huong N, Plantier JC, Burgard M, Peeters M, Damond F, Ekouevi DK, Msellati P, et al: Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J Acquir Immune Defic Syndr. 2007, 45: 380-388. 10.1097\/QAI.0b013e3180640cf5.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1363_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jviromet.2006.03.015","volume":"135","author":"MN Didelot-Rousseau","year":"2006","unstructured":"Didelot-Rousseau MN, Courgnaud V, Nagot N, Ouedraogo A, Konate I, Mayaud P, Weiss H, Van de Perre P, Segondy M: Comparison of INNO-LiPA HPV Genotyping v2 with PCR product subcloning and sequencing for identification of genital human papillomavirus genotypes in African women. J Virol Methods. 2006, 135: 181-185. 10.1016\/j.jviromet.2006.03.015.","journal-title":"J Virol Methods"},{"key":"1363_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1046\/j.1365-2303.2002.00397.x","volume":"13","author":"JH Smith","year":"2002","unstructured":"Smith JH: Bethesda 2001. Cytopathology. 2002, 13: 4-10. 10.1046\/j.1365-2303.2002.00397.x.","journal-title":"Cytopathology"},{"key":"1363_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1158\/1055-9965.EPI-09-0546","volume":"19","author":"X Xue","year":"2010","unstructured":"Xue X, Gange SJ, Zhong Y, Burk RD, Minkoff H, Massad LS, Watts DH, Kuniholm MH, Anastos K, Levine AM, et al: Marginal and mixed-effects models in the analysis of human papillomavirus natural history data. Cancer Epidemiol Biomarkers Prev. 2010, 19: 159-169. 10.1158\/1055-9965.EPI-09-0546.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1363_CR23","volume-title":"Sex Transm Infect","author":"A Low","year":"2010","unstructured":"Low A, Didelot-Rousseau MN, Nagot N, Ouedraougo A, Clayton T, Konate I, Van de Perre P, Segondy M, Mayaud P: Cervical infection with human papillomavirus (HPV) 6 or 11 in high-risk women in Burkina Faso. Sex Transm Infect. 2010"},{"key":"1363_CR24","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1128\/JCM.41.9.4451-4453.2003","volume":"41","author":"P Mayaud","year":"2003","unstructured":"Mayaud P, Weiss HA, Lacey CJ, Gill DK, Mabey DC: Genital human papillomavirus genotypes in northwestern Tanzania. J Clin Microbiol. 2003, 41: 4451-4453. 10.1128\/JCM.41.9.4451-4453.2003.","journal-title":"J Clin Microbiol"},{"key":"1363_CR25","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1128\/JVI.71.9.6427-6432.1997","volume":"71","author":"K Hong","year":"1997","unstructured":"Hong K, Greer CE, Ketter N, Van Nest G, Paliard X: Isolation and characterization of human papillomavirus type 6-specific T cells infiltrating genital warts. J Virol. 1997, 71: 6427-6432.","journal-title":"J Virol"},{"key":"1363_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.virol.2006.07.032","volume":"356","author":"S Jain","year":"2006","unstructured":"Jain S, Moore RA, Anderson DM, Gough GW, Stanley MA: Cell-mediated immune responses to COPV early proteins. Virology. 2006, 356: 23-34. 10.1016\/j.virol.2006.07.032.","journal-title":"Virology"},{"key":"1363_CR27","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1086\/427777","volume":"191","author":"DH Watts","year":"2005","unstructured":"Watts DH, Fazzari M, Minkoff H, Hillier SL, Sha B, Glesby M, Levine AM, Burk R, Palefsky JM, Moxley M, et al: Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis. 2005, 191: 1129-1139. 10.1086\/427777.","journal-title":"J Infect Dis"},{"key":"1363_CR28","volume-title":"Book Feasibility and efficacy of highly active antiretroviral therapy among high-risk and marginalised HIV-1 infected women in West Africa","author":"C Huet","year":"2009","unstructured":"Huet C, Ouedraogo A, Konate I, Traore I, Rouet F, Ouiminga A, A S, Mayaud P, Van de Perre P, Nagot N: Feasibility and efficacy of highly active antiretroviral therapy among high-risk and marginalised HIV-1 infected women in West Africa. Book Feasibility and efficacy of highly active antiretroviral therapy among high-risk and marginalised HIV-1 infected women in West Africa. 2009, City"},{"key":"1363_CR29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1086\/650467","volume":"201","author":"H Minkoff","year":"2010","unstructured":"Minkoff H, Zhong Y, Burk RD, Palefsky JM, Xue X, Watts DH, Levine AM, Wright RL, Colie C, D'Souza G, et al: Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Infect Dis. 2010, 201: 681-690. 10.1086\/650467.","journal-title":"J Infect Dis"},{"key":"1363_CR30","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1086\/498164","volume":"192","author":"P Vandepapeliere","year":"2005","unstructured":"Vandepapeliere P, Barrasso R, Meijer CJ, Walboomers JM, Wettendorff M, Stanberry LR, Lacey CJ: Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination. J Infect Dis. 2005, 192: 2099-2107. 10.1086\/498164.","journal-title":"J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-11-20\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-11-20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T21:23:03Z","timestamp":1592256183000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-11-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,20]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1363"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-11-20","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,20]]},"article-number":"20"}}